Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline vs Vancomycin/Aztreonam in cSSTI
NCT02202135Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of ceftaroline fosamil in skin and soft tissue infection (SSTI), sponsored by Pfizer. Started Jun 2014; status: terminated.
02
Drugs
ceftaroline fosamil
03
Conditions
skin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT02202135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202135.